Phase 2 Exon 14 Skipping Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Pancreatic CancerGastric CancerLung Cancer+15 more

Apollomics Inc.497 enrolled35 locationsNCT03175224

Completed

Phase 2

Cancer Molecular Screening and Therapeutics (MoST) Program Addendum 17 - substudies 38-39: Tepotinib

Advanced non-small cell lung cancer harbouring MET exon 14 skipping mutations

The University of Sydney32 enrolled12 locationsACTRN12621000811808